OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Covalent cannabinoid receptor ligands – structural insight and selectivity challenges	119
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery	88
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents	68
Synthesis and biological evaluation of novel D-ring fused steroidal N(2)-substituted-1,2,3-triazoles	60
Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D₂ synthase	58
Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity	57
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans	57
Back cover	55
Back cover	52
Contents list	52
Back cover	47
Inside front cover	44
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking	43
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections	43
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery	38
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape	38
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation	38
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators	33
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition	32
Research progress of anticancer drugs targeting CDK12	30
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer	28
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond	28
Identification of the first structurally validated covalent ligands of the small GTPase RAB27A	27
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells	27
Emerging opportunities in the rewiring of biology through proximity inducing small molecules.	26

Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure	26
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy	26